Search Results - Paul D van Helden

Differences in primary sites of infection between zoonotic and human tuberculosis: results from a worldwide systematic review. by Salome Dürr, Borna Müller, Silvia Alonso, Jan Hattendorf, Cláudio J M Laisse, Paul D van Helden, Jakob Zinsstag

Connect to this object online.

A Subgroup of Latently Mycobacterium tuberculosis Infected Individuals Is Characterized by Consistently Elevated IgA Responses to Several Mycobacterial Antigens by Ralf Baumann, Susanne Kaempfer, Novel N. Chegou, Wulf Oehlmann, Ralf Spallek, André G. Loxton, Paul D. van Helden, Gillian F. Black, Mahavir Singh, Gerhard Walzl

Connect to this object online.

One Health approach in the prevention and control of mycobacterial infections in Tanzania: lessons learnt and future perspectives by Bugwesa Z. Katale, Erasto V. Mbugi, Julius D. Keyyu, Robert D. Fyumagwa, Mark M. Rweyemamu, Paul D. van Helden, Hazel M. Dockrell, Mecky I. Matee

Connect to this object online.

Drug susceptibility testing using molecular techniques can enhance diagnosis in a community with a high tuberculosis incidence by Rabia Johnson,1 Annemie M. Jordaan,1 Rob Warren,1 Marleine Bosman,2 Douglas Young,3 Judit N. Nagy,3 John R. Wain,4 Paul D. van Helden,1 Thomas C. Victor.1

Connect to this object online.

Identification of a novel WAS mutation in a South African patient presenting with atypical Wiskott-Aldrich syndrome: a case report by Brigitte Glanzmann, Marlo Möller, Mardelle Schoeman, Michael Urban, Paul D. van Helden, Lisa Frigati, Ravnit Grewal, Hermanus Pieters, Ben Loos, Eileen G. Hoal, Richard H. Glashoff, Helena Cornelissen, Helena Rabie, Monika M. Esser, Craig J. Kinnear

Connect to this object online.